Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life-experience of the French Network.
Saved in:
| Title: | Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life-experience of the French Network. |
|---|---|
| Authors: | Schenone L; Université de Lorraine, Department of Hematology, CHRU de Nancy, Hôpital de Brabois, Nancy, France., Houillier C; Department of Neurology, APHP, Sorbonne Université, IHU, ICM, Groupe Hospitalier Pitié-Salpêtrière, Paris, France., Tanguy ML; Department of Biostatistics, Institut Gustave Roussy, Villejuif, Paris, France., Choquet S; Department of Hematology, APHP, Sorbonne Université, Hôpital Pitié-Salpêtrière, Paris, France., Agbetiafa K; Department of Hematology, Institut Curie, Site Saint-Cloud, France., Ghesquières H; Department of Hematology, Centre Hospitalier Lyon Sud, Lyon, France., Damaj G; Department of Hematology, CHU de Caen Normandie, Caen, France., Schmitt A; Department of Hematology, Institut Bergonié, Bordeaux, France., Bouabdallah K; Department of hematology and cell therapy, University Hospital of Bordeaux, F-33000, Bordeaux, France., Ahle G; Department of Neurology Pôle NNORR, Hôpitaux Civils de Colmar, Colmar, France., Gressin R; Department of Hematology, CHU de Grenoble, Grenoble, France., Cornillon J; Department of Hematology, Institut de Cancérologie Lucien Neuwirth, Saint-Priest-en-Jarez, France., Houot R; Department of Hematology, CHU Rennes, Rennes, France., Marolleau JP; Department of Hematology, CHU Amiens, Amiens, France., Fornecker LM; Department of Hematology, Institut de Cancérologie Strasbourg Europe, Strasbourg, France., Chinot O; Department of Neuro-oncology, AP-HM, CHU Timone, Marseille, France., Peyrade F; Department of Hematology, Centre Antoine Lacassagne, Nice, France., Bouabdallah R; Hôpital Privé de Provence, Pôle de cancérologie, Aix-en-Provence, France., Moluçon-Chabrot C; Department of Hematology, CHU Clermont-Ferrand, Clermont-Ferrand, France., Gyan E; Department of Hematology and Cellular Therapy, CHU de Tours, Tours, France., Chauchet A; Department of Hematology, CHRU de Besançon, Besançon, France., Casasnovas O; Department of Hematology, CHU Dijon Bourgogne, Dijon, France., Oberic L; Department of Hematology, Institut Universitaire du Cancer de Toulouse, Toulouse, France., Delwail V; Department of Hematology and cellular Therapy, CHU de Poitiers, Poitiers, France., Abraham J; Department of Hematology, CHU Dupuytren Limoges, Limoges, France., Roland V; Department of Hematology, CH Saint Jean, Perpignan, France., Waultier-Rascalou A; Department of Hematology, CHU Nimes Caremeau, Nimes, France., Willems L; Department of Hematology, CHU Paris Centre Site Cochin, Paris, France., Morschhauser F; Institute of Hematology-transfusion, CHRU de Lille, Lille, France., Fabbro M; Department of Oncology, Institut regional cancer Montpellier, Montpellier, France., Ursu R; Department of Neurology, AP-HP, Hôpital Saint-Louis, Paris, France., Thieblemont C; Department of Hematology, AP-HP, Hôpital Saint-Louis, Paris, France., Jardin F; Department of Hematology, Centre Henri Becquerel, Rouen, France., Tempescul A; Department of Hematology, CHRU de Brest, Brest, France., Malaise D; Department of Ophthalmology, Institut Curie, Paris, France.; Institut Curie, PSL University, Inserm U1288, Laboratoire d'Imagerie Translationnelle en Oncologie, Orsay, France., Touitou V; Department of Ophthalmology, APHP, Hôpital Pitié-Salpêtrière, Paris, France., Nichelli L; Department of Neuro-radiology, APHP, Hôpital Pitié-Salpêtrière, Paris, France., Le Garff-Tavernier M; Department of biological Hematology, APHP, Hôpital Pitié-Salpêtrière, Paris, France., Plessier A; Department of Hepato gastroenterology, APHP, Hôpital Beaujon, Paris, France., Bourget P; Department of functional explorations, APHP, Hôpital Necker, Paris, France., Bonmati C; Department of Hematology, CHRU de Nancy, Hôpital de Brabois, Nancy, France., Wantz-Mézières S; Université de Lorraine, CNRS, Inria, IECL, F-54000, Nancy, France., Giordan Q; Pharmacy department, CHR Metz-Thionville, Hôpital de Mercy, Metz, France., Dorvaux V; Department of Hematology, CHR Metz-Thionville, Hôpital de Mercy, Metz, France., Charron C; Intensive care department, University Hospital Ambroise Paré, AP-HP, Boulogne-Billancourt, France., Jabeur W; Department of Neurology, Hôpital Foch, Suresnes, France., Hoang-Xuan K; Department of Neurology, APHP, Sorbonne Université, IHU, ICM, Groupe Hospitalier Pitié-Salpêtrière, Paris, France., Taillandier L; Department of Neurology, CHRU de Nancy, Hôpital Central, Nancy, France., Soussain C; Department of Hematology, Institut Curie, Site Saint-Cloud, France. carole.soussain@curie.fr.; INSERM U932 Institut Curie, PSL Research University, Paris, France. carole.soussain@curie.fr. |
| Corporate Authors: | French network for oculocerebral lymphoma (LOC network) |
| Source: | Bone marrow transplantation [Bone Marrow Transplant] 2022 Jun; Vol. 57 (6), pp. 966-974. Date of Electronic Publication: 2022 Apr 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
